H.R. 6513 · 117th Congress
Medical Innovation Acceleration Act of 2022
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
BiggsSponsorNo cosponsors.
This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
What it does: CRS summary · Introduced in House · Jan 28, 2022
Medical Innovation Acceleration Act of 2022
This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medical Innovation Acceleration Act of 2022
Latest action (Jan 31, 2022): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jan 28, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.